tradingkey.logo

Movano Inc

MOVE
15.020USD
+10.250+214.88%
Market hours ETQuotes delayed by 15 min
12.47MMarket Cap
LossP/E TTM

Movano Inc

15.020
+10.250+214.88%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Movano Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Movano Inc's Score

Industry at a Glance

Industry Ranking
116 / 209
Overall Ranking
255 / 4614
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Movano Inc Highlights

StrengthsRisks
Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.01M.
Overvalued
The company’s latest PE is -0.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 125.40K shares, decreasing 11.48% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.42K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.92.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.56, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
7.56
Change
0

Financials

9.84

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

8.72

Operational Efficiency

2.68

Growth Potential

9.17

Shareholder Returns

7.38

Movano Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 7.49, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.17, which is -70.34% below the recent high of -0.05 and -34886.88% above the recent low of -60.28.

Score

Industry at a Glance

Previous score
7.49
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 116/209
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Movano Inc is 30.00, with a high of 30.00 and a low of 30.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

89
Total
4
Median
7
Average
Company name
Ratings
Analysts
Movano Inc
MOVE
1
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
34
Thermo Fisher Scientific Inc
TMO
28
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 6.16, which is lower than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 6.62 and the support level at 3.79, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.08
Change
0.08

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.840
Neutral
RSI(14)
46.931
Neutral
STOCH(KDJ)(9,3,3)
5.132
Oversold
ATR(14)
0.560
High Vlolatility
CCI(14)
-117.746
Sell
Williams %R
96.269
Oversold
TRIX(12,20)
2.670
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
5.223
Buy
MA10
5.878
Buy
MA20
6.475
Buy
MA50
3.139
Buy
MA100
1.903
Buy
MA200
2.093
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.42. The latest institutional shareholding proportion is 15.02%, representing a quarter-over-quarter decrease of 67.44%. The largest institutional shareholder is Mairs and Power, holding a total of 37.53K shares, representing 4.50% of shares outstanding, with 20.55% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Appel (Peter A)
648.80K
--
Mastrototaro (John)
246.22K
--
Clayton Partners LLC
400.00K
+178.79%
Mairs and Power, Inc.
Star Investors
375.34K
--
Cogan (Jeremy D.)
236.30K
--
Fairbairn (Malcolm P.)
367.57K
--
Robert W. Baird & Co. Inc.
218.73K
-32.48%
Leabman (Michael Aaron)
216.16K
--
Cullinan (Brian)
118.36K
--
Fairbairn Emily Wang
120.29K
-75.34%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 1.22, which is lower than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.85. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
1.22
Change
0
Beta vs S&P 500 index
0.85
VaR
--
240-Day Maximum Drawdown
+91.93%
240-Day Volatility
+287.80%

Return

Best Daily Return
60 days
+912.33%
120 days
+912.33%
5 years
--
Worst Daily Return
60 days
-20.88%
120 days
-21.41%
5 years
--
Sharpe Ratio
60 days
+2.04
120 days
+1.40
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+91.93%
3 years
+98.28%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.54
3 years
-0.27
5 years
--
Skewness
240 days
+14.92
3 years
+25.23
5 years
--

Volatility

Realised Volatility
240 days
+287.80%
5 years
--
Standardised True Range
240 days
+5.91%
5 years
--
Downside Risk-Adjusted Return
120 days
+2150.52%
240 days
+2150.52%
Maximum Daily Upside Volatility
60 days
+1957.70%
Maximum Daily Downside Volatility
60 days
+1584.74%

Liquidity

Average Turnover Rate
60 days
+37.81%
120 days
+22.34%
5 years
--
Turnover Deviation
20 days
+692.29%
60 days
+234.60%
120 days
+97.71%

Peer Comparison

Healthcare Equipment & Supplies
Movano Inc
Movano Inc
MOVE
6.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI